Breast Density and Notification Laws

Our Position

In the states, ACOG advocates against legislation that prescribes what must be communicated to patients about breast density and cancer risk, especially when the information is contrary to evidence-based scientific data and medical consensus.

There is no reliable (objective and quantitative) method for assessing breast density; no clinical guidelines recommend additional screening solely on the basis of high breast density; and breast density is not a major cancer risk factor.